Back to Trades
Tenjarla Srini
SVPCMC & FormulationCIK 0002029985
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Tenjarla Srini, SVP, CMC & Formulation, has filed 2 SEC reports (2026), all concentrated in Serina Therapeutics, Inc. (SER), totaling $352.1K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| May 26 | SER Serina Therapeutics, Inc. | Tenjarla Srini | SVP, CMC & Formulation | Award | $161.7K |
| Feb 17 | SER Serina Therapeutics, Inc. | Tenjarla Srini | SVP, CMC & Formulation | Award | $190.4K |
2 filings